UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 336

Sortiert nach

STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany

BMC infectious diseases, 2020-02, Vol.20 (1), p.110-110, Article 110

2020

Volltextzugriff (PDF)

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

The New England journal of medicine, 2013-11, Vol.369 (19), p.1807-1818

2013

Volltextzugriff (PDF)

O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 3 YEAR FINAL RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S51-S51

2014

Volltextzugriff (PDF)

Learning in Public Policy: Analysis, Modes and Outcomes

1st ed. 2018., 2018

Volltextzugriff (PDF)

Effects of dexmedetomidine combined with ropivacaine on sciatic and femoral nerve blockade in dogs

Veterinary anaesthesia and analgesia, 2017-01, Vol.44 (1), p.144-153

2017

Volltextzugriff (PDF)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals

European journal of medical research, 2010-03, Vol.15 (3), p.102-102, Article 102

2010

Volltextzugriff (PDF)

Pulmonary hemodynamics and alveolar oxygenation in healthy dogs anesthetized with propofol or isoflurane during one-lung ventilation in a closed-thoracic experimental model

American journal of veterinary research, 2017-10, Vol.78 (10), p.1117-1125

2017

Volltextzugriff (PDF)

AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999–2018

Infection, 2024-04, Vol.52 (2), p.637-648

2024

Volltextzugriff (PDF)

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

PloS one, 2010-10, Vol.5 (10), p.e12718-e12718

2010

Volltextzugriff (PDF)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort

PloS one, 2019-01, Vol.14 (1), p.e0209605-e0209605

2019

Volltextzugriff (PDF)

Safety of long-term lopinavir plasma-levels in patients with liver disease

European journal of medical research, 2008-05, Vol.13 (5), p.205

2008

Volltextzugriff (PDF)

A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial

The open AIDS journal, 2011, Vol.5 (1), p.44-50, Article 44

2011

Volltextzugriff (PDF)

768 EFFECTIVENESS OF TENOFOVIR FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 2 YEAR INTERIM RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY (GEMINIS)

Journal of hepatology, 2013-04, Vol.58, p.S313-S313

2013

Volltextzugriff (PDF)

Comparison of two volumes for sciatic perineural injection using 1% methylene blue in rabbit cadavers

Arquivo brasileiro de medicina veterinária e zootecnia, 2021-12, Vol.73 (6), p.1309-1314

2021

Volltextzugriff (PDF)

Avaliação da maturidade pulmonar de cabritos nascidos a termo e prematuros

Arquivo brasileiro de medicina veterinária e zootecnia, 2020-08, Vol.72 (4), p.1313-1320

2020

Volltextzugriff (PDF)

Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir

AIDS (London), 2004-04, Vol.18 (6), p.952-955

2004

Volltextzugriff (PDF)

Efficacy of DAAs-based HCV triple therapy in HIV-HCV-coinfected patients: interim 24-week results

Antiviral therapy, 2013-01, Vol.18, p.A13-A13

2013

Volltextzugriff (PDF)

Treatment response to LPV/r‐based HAART in HIV‐infected patients aged >60 years ‐ data from the STAR/STELLA cohorts

Journal of the International AIDS Society, 2012-11, Vol.15 (S4), p.1-2

2012

Volltextzugriff (PDF)

Median Problem Pressure and Policy Learning: An Exploratory Analysis of European Countries

Learning in Public Policy, 2018, p.243-266

2018

Volltextzugriff (PDF)

Mitochondrial DNA and sperm quality in patients under antiretroviral therapy

AIDS (London), 2003-02, Vol.17 (3), p.450-451

2003

Volltextzugriff (PDF)

Use of lopinavir/ritonavir in first-line therapy or second-line therapy: 48-week results from the German prospective STAR cohort

Journal of the International AIDS Society, 2008-11, Vol.11 (Suppl 1), p.P75-P75

2008

Volltextzugriff (PDF)

Similar virological response rates for ART-naïve subjects starting KVX + LPV/r or TVD+ LPV/r. Data from the prospective observational STAR cohort

Journal of the International AIDS Society, 2008-11, Vol.11 (S1), p.P7-P7, Article P7

2008

Volltextzugriff (PDF)

Introduction: The Family Tree of Policy Learning

Learning in Public Policy, 2018, p.1-25

2018

Volltextzugriff (PDF)

Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir

AIDS (London), 2004-04, Vol.18 (6), p.952-955

2004

Volltextzugriff (PDF)

Lessons Learned and Not Learned: Bibliometric Analysis of Policy Learning

Learning in Public Policy, 2018, p.27-49

2018

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(311)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 3 YEAR FINAL RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY

Learning in Public Policy: Analysis, Modes and Outcomes

Effects of dexmedetomidine combined with ropivacaine on sciatic and femoral nerve blockade in dogs

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals

Pulmonary hemodynamics and alveolar oxygenation in healthy dogs anesthetized with propofol or isoflurane during one-lung ventilation in a closed-thoracic experimental model

AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999–2018

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort

Safety of long-term lopinavir plasma-levels in patients with liver disease

A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial

768 EFFECTIVENESS OF TENOFOVIR FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 2 YEAR INTERIM RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY (GEMINIS)

Comparison of two volumes for sciatic perineural injection using 1% methylene blue in rabbit cadavers

Avaliação da maturidade pulmonar de cabritos nascidos a termo e prematuros

Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir

Efficacy of DAAs-based HCV triple therapy in HIV-HCV-coinfected patients: interim 24-week results

Treatment response to LPV/r‐based HAART in HIV‐infected patients aged >60 years ‐ data from the STAR/STELLA cohorts

Median Problem Pressure and Policy Learning: An Exploratory Analysis of European Countries

Mitochondrial DNA and sperm quality in patients under antiretroviral therapy

Use of lopinavir/ritonavir in first-line therapy or second-line therapy: 48-week results from the German prospective STAR cohort

Similar virological response rates for ART-naïve subjects starting KVX + LPV/r or TVD+ LPV/r. Data from the prospective observational STAR cohort

Introduction: The Family Tree of Policy Learning

Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir

Lessons Learned and Not Learned: Bibliometric Analysis of Policy Learning

Suchergebnisse filtern